Xareltos Lawsuit

Kelley Law Firm, PC lawyers are currently investigating serious bleeding incidents in the brain and gastrointestinal track linked to the use of Xarelto, an alternative oral antiocoagulant drug prescribed to prevent blood clots.

Xarelto bleeding lawsuits are now being filed against Bayer and Jassen Pharmaceuticals as a result of serious uncontrollable bleeding incidents experienced by patients. Unlike Warfin, the traditional blood thinning drug, there is no current reversal agent for Xarelto, making it a particularly dangerous drug.

The Xarelto lawyers at Kelley Law Firm, PC are currently investigating the serious and potentially fatal side effects linked to Xarelto. If you or a loved one has experienced serious bleeding incidents or other serious side effects linked to Xarelto, please contact us. You may be eligible to file a Xarelto lawsuit.

What is Xarelto?

inhibitors. Xarelto was approved by the U.S. Food & Drug in 2011 to treat the following:

Reduce the risk of stroke and blood cloths in people with atrial fibrillation, not caused by a heart valve problem.
Treat deep vein thrombosis and pulmonary embolism and;
Reduce the risk of forming a blood clot in the legs and lungs of adults recovering from knee or hip surgery.
Xarelto was invented and manufactured by Bayer before 2008. In the United States, it is marketed by Jassen Pharmaceuticals, a division of Johnson & Johnson, as an alternative to Warfin because Xarelto does not require blood monitoring. However, many users have found that the convenience of Xarelto does not warrant its risk of serious side effects.

Xarelto Drug Safety Alerts

The Institute for Safe Medication Practices, an independent health nonprofit group that monitors FDA MedWatch Reports, has called anticoagulant drugs, like Xarelto and Pradaxa, “a high-risk treatment that causes bleeding in approximately 15 percent of patients with atrial fibrillation exposed for a year.”

In 2012, the FDA received hundreds of reports of adverse events in Xarelto users. In Q1 of 2013, 638 adverse reports linked to Xarelto use were submitted through the FDA’s MedWatch Reporting system. ISMP cited the increase to more prescriptions of Xarelto being dispensed. However, it stressed that the safety of anticoagulant drugs remain a major concern given the high risks of bleeding and increased use.

Because of Xarelto’s increased risk of uncontrollable bleeding, the FDA rejected a bid from Bayer and J&J to approve the drug for use in prevention of new heart attacks and strokes, and death, in patients with acute coronary syndrome. According to Reuters, FDA panel members said the benefit of the drug was not shown to outweigh an increased risk of bleeding.

Xarelto Bleeding Side Effects

Xarelto can cause serious bleeding because of how it affects blood clotting proteins. Notify your doctor immediately if you notice any of the following signs of serious bleeding while taking Xarelto.

Unusual pain, swelling or discomfort
Unusual bruising
Prolonged bleeding from cuts or gums
Persistent and/or frequent nose bleeds
Unusually heavy or prolonged menstrual flow
Coughing up blood
Dark urine and/or tarry stools
Vomit that is blood or looks like coffee grounds
Severe headache, dizzieness or fainting
Unusuall or persistent tiredness and fatigue
Difficulty swallowing
Xarelto Legal Consultation

The Xarelto lawyers at Kelley Law Firm, PC are investigating the legal rights of people who suffered significant injuries while taking Xarelto. The drug companies responsible for Xarelto may have failed in its duty to adequately warn consumers about the increased risk of bleeding events compared to other anticoagulant drugs.

Contact us for more information regarding your specific situation. Our experienced Xarelto lawyers will evaluate your case, answer your questions and help you understand your legal rights in regards to filing a Xarelto lawsuit.

Related Posts